Early Bird Registration for NETA’s PowerTest 2018 Conference Opens September 1, 2017
Aug 31, 2017 11:15 am UTC| Business
PORTAGE, Mich., Aug. 31, 2017 -- NETA’s PowerTest 2018 technical agenda offers five days of high-powered learning and interactive sessions for electrical power systems professionals from February 26 - March 2, 2018, at...
Aug 31, 2017 11:05 am UTC| Business
SAN JUAN, Puerto Rico, Aug. 31, 2017 -- Green Spirit Industries Inc. (OTC Pink:GSRX) (“Green Spirit” or, the “Company”) through its wholly-owned subsidiary, Project 1493 LLC, has announced today that it has commenced...
Aug 31, 2017 11:05 am UTC| Business
HALIFAX, Nova Scotia, Aug. 31, 2017 -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced the achievement of several milestones in its ongoing collaboration with global...
RedHill Biopharma to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
Aug 31, 2017 11:00 am UTC| Business
TEL-AVIV, Israel and RALEIGH, N.C., Aug. 31, 2017 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late...
Assembly Biosciences Announces September Conference Participation
Aug 31, 2017 11:00 am UTC| Business
INDIANAPOLIS, Aug. 31, 2017 -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel...
EnviroLeach Announces Partnership with Jabil for E-Waste Processing
Aug 31, 2017 11:00 am UTC| Business
VANCOUVER, British Columbia, Aug. 31, 2017 -- EnviroLeach Technologies Inc. (CSE:ETI) (OTCQB:EVLLF), is pleased to announce that it has entered into a strategic global partnership with Jabil Inc. (NYSE:JBL). As part of...
Apricus Biosciences Announces FDA Acknowledgement of Vitaros™ Class 2 NDA Resubmission
Aug 31, 2017 11:00 am UTC| Business
SAN DIEGO, Aug. 31, 2017 -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the U.S. Food and Drug Administration...